KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Non-Current Deffered Revenue: 2010-2014

Historic Non-Current Deffered Revenue for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $3.6 million.

  • Biocryst Pharmaceuticals' Non-Current Deffered Revenue rose 163.05% to $10.1 million in Q3 2015 from the same period last year, while for Sep 2015 it was $10.1 million, marking a year-over-year increase of 163.05%. This contributed to the annual value of $3.6 million for FY2014, which is 25.00% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Non-Current Deffered Revenue of $3.6 million as of FY2014, which was down 25.00% from $4.7 million recorded in FY2013.
  • Biocryst Pharmaceuticals' Non-Current Deffered Revenue's 5-year high stood at $15.9 million during FY2010, with a 5-year trough of $3.6 million in FY2014.
  • Over the past 3 years, Biocryst Pharmaceuticals' median Non-Current Deffered Revenue value was $4.7 million (recorded in 2013), while the average stood at $4.7 million.
  • Data for Biocryst Pharmaceuticals' Non-Current Deffered Revenue shows a maximum YoY crashed of 55.45% (in 2011) over the last 5 years.
  • Yearly analysis of 5 years shows Biocryst Pharmaceuticals' Non-Current Deffered Revenue stood at $15.9 million in 2010, then slumped by 55.45% to $7.1 million in 2011, then decreased by 16.65% to $5.9 million in 2012, then fell by 20.00% to $4.7 million in 2013, then decreased by 25.00% to $3.6 million in 2014.